The Aromasin is an aromatase inhibitor and is commonly used in the adjuvant treatment of postmenopausal women with invasive breast cancer at an early stage, and estrogen receptor positive, following initial adjuvant tamoxifen therapy for 2-3 years.Aromasin – Exemestane Structural formula of exemestane, active ingredient in Aromasin. AROMASIN is also indicated in the treatment of … Continue reading Aromasin. Aromatase inhibitors.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed